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SUMMAry Factorial designs for clinical trials are often encountered in medical, dental, and orthodontic 
research. Factorial designs assess two or more interventions simultaneously and the main advantage of 
this design is its efficiency in terms of sample size as more than one intervention may be assessed on 
the same participants. However, the factorial design is efficient only under the assumption of no interac-
tion (no effect modification) between the treatments under investigation and, therefore, this should be 
considered at the design stage. Conversely, the factorial study design may also be used for the purpose 
of detecting an interaction between two interventions if the study is powered accordingly. However, a 
factorial design powered to detect an interaction has no advantage in terms of the required sample size 
compared to a multi-arm parallel trial for assessing more than one intervention. It is the purpose of this 
article to highlight the methodological issues that should be considered when planning, analysing, and 
reporting the simplest form of this design, which is the 2 × 2 factorial design. An example from the field 
of orthodontics using two parameters (bracket type and wire type) on maxillary incisor torque loss will 
be utilized in order to explain the design requirements, the advantages and disadvantages of this design, 
and its application in orthodontic research.
Introduction
A common aim of clinical research in dentistry is the evalu-
ation of the effectiveness of different treatment or prevention 
strategies on clinical or patient-reported outcomes. Among 
the different clinical research study designs, randomized 
controlled trials (RCTs) command the highest level in terms 
of quality in the hierarchy of evidence for the assessment 
of the effects and safety of an intervention (Moher et al., 
2010).
RCTs may be implemented using a plethora of study 
designs depending on the interventions to be evaluated, the 
settings, the resources, and practicalities. The most common 
RCT design explores the effect of two or more interventions 
at a time in a parallel fashion. Two groups of patients are 
randomly allocated to the two therapies (or therapy and 
control) and are followed prospectively. Another design is 
the crossover (Chan and Altman, 2005), in which, in the 
simplest form, the same groups of patients are randomly 
allocated to the two interventions during the first stage, a 
wash-out period follows, and during the second stage, treat-
ment allocation is reversed so that all patients receive both 
interventions either during stage 1 or 2. The closest design 
to crossover in dentistry is the split-mouth design (Pandis 
et al., 2012). The clustered design (Campbell et al., 2004) 
allocates interventions to groups of patients and its exten-
sion in orthodontics is the design in which multiple obser-
vations (teeth nested in patients) are selected per patient 
(Pandis et  al., 2013). The non-inferiority design aims to 
establish equivalence or non-inferiority of a newer inter-
vention compared with the standard (Piaggio et al., 2006). 
Finally, the factorial fashion (Montgomery et  al., 2003) 
design is used, in which two or more interventions may be 
evaluated on the same sample of patients.
The various RCT designs with their different character-
istics possess certain advantages and disadvantages, which 
make them more suitable in specific settings. However, 
classification is not too rigid as some of the designs may 
be a hybrid of two or more specific designs (Peters et al., 
2003; Bahrami et al., 2004). Additionally, the type of trial 
design requires different provisions for the number of par-
ticipants to be included and for appropriate data analysis 
methodology.
A parallel design randomly assigns one or more 
interventions to two or more groups of participants, follows 
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them prospectively, and compares effects between treatment 
arms. A  parallel design may have two or more arms and 
each participant is randomized to one and only treatment. 
The parallel design is the most common approach (Chan 
and Altman, 2005), which however, is not always the most 
efficient. The loss in efficiency is associated with the fact that 
when multiple therapies (treatment arms) are investigated, 
they require many patients in order to get precise estimates, 
thus increasing trial cost and resources.
In certain situations, it is possible to evaluate two or more 
interventions simultaneously in a single trial (Hennekens 
et  al., 1996; McAlister et  al., 2003; Piantadosi, 2005). 
This may be accomplished by following a factorial study 
design. The simplest design takes the form of a 2 × 2 
design (two treatments with two levels each), neverthe-
less higher-order factorial designs are possible and have 
been reported (The PARAGON Investigators, 1998; Apfel 
et  al., 2003, 2004; McAlister et  al., 2003). The advan-
tages of the factorial design are related to the fact that 
two or more parameters may be assessed at the same time 
in the same population simultaneously, thus creating a 
more efficient trial in terms of resources including sam-
ple size compared with separate trials for assessment of 
each parameter (Montgomery et al., 2003). However, the 
assumptions that the two treatments may be combined and 
that there is no interaction (or effect modification) must be 
satisfied (Ottenbacher, 1991). Interaction (or effect modi-
fication) is present when the effect of one variable on an 
outcome is modified according to the level of a second 
variable (Altman and Bland, 2003). For example, if we 
are assessing the effect of the type of orthodontic treat-
ment on maxillary incisor resorption and we find that the 
effect of the type of appliance is different with different 
types of wire, then we may say that we have evidence of 
interaction or effect modification between the intervention 
(bracket type) and the wire type. In such a situation, a fac-
torial design that would explore the effect of the type of 
bracket and wire type on root resorption simultaneously 
in the same sample would not be appropriate. In the case 
where no interaction exists, a factorial design would prob-
ably be an appropriate and efficient method in evaluating 
the effect of two therapies.
It is the purpose of this article to highlight the methodologi-
cal issues that should be considered when planning, analys-
ing, and reporting the simplest form of this design, which is 
the 2 × 2 factorial design. An example from the field of ortho-
dontics using two parameters (bracket type and wire type) on 
maxillary incisor torque loss will be utilized in order to explain 
the design requirements, the advantages and disadvantages of 
this design, and its application in dental orthodontic research.
Advantages
1. A  factorial design is more efficient mainly due to the 
smaller sample size required (up to one-half) compared 
with two separate two-arm parallel trials. The efficiency 
in terms of sample size of the factorial design that tests 
two interventions at the same time is valid under the 
assumption that no interaction is present between the 
two interventions. However, it must be kept in mind that 
‘interaction tests have low power’ and absence of sig-
nificant interaction is not absolute proof of no interaction 
(Lubsen and Pocock, 1994).
2. A factorial design is the only design that allows testing for 
interaction; however, designing a study ‘to specifically’ 
test for interaction will require a much larger sample size, 
and therefore it is essential that the trial is powered to 
detect an interaction effect (Brookes et al., 2001).
3. Reduced costs, reduced recourses and management 
needs are found due to the fact that a smaller sample will 
be required compared with two separate trials.
Disadvantages
1. A factorial design may require extra time, compliance, 
and management of applying two treatments at the same 
time.
2. Data analysis and randomization may be a little more 
complex because participants must be allocated to four 
arms either in one (A, B, C, and D) or two stages (first 
intervention and comparator, and then second inter-
vention and its comparator (Montgomery et  al., 2003; 
Machin and Fayers, 2010)
3. Appropriateness and acceptability/tolerance of the com-
bined intervention on biologic and scientific grounds 
must be explored and determined (Brittain and Wittes, 
1989).
4. If interaction is expected, but there is no intention to 
detect the interaction, the factorial has no sample size 
advantages compared with two separate two-arm par-
allel trials. In other words, in this scenario, the sample 
size will be double the size of the factorial with no 
interaction or equal to the size of two 2-arm parallel 
trials (Brookes et al., 2001). Therefore, the investiga-
tors must be as sure as possible that no interaction is 
present between the two interventions when under-
taking a factorial design in which they would like to 
assess simultaneously the effect of two treatments. If 
the objective is to specifically detect interaction, the 
sample increases by 4-fold compared with the factorial 
with no interaction when we want to observe an inter-
action effect equal to the effect to be detected between 
the two arms of the parallel trial (Brittain and Wittes, 
1989; Brookes et al., 2001; Montgomery et al., 2003; 
Piantadosi, 2005)
Randomization
Randomization in factorial designs may follow similar 
and appropriate methods used with parallel trials, such as 
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simple, restricted, stratified randomization, or minimization 
(Pandis et  al., 2011). One difference is that individuals 
must be randomized more than once depending on the 
factorial design. In a 2 × 2 factorial design, participants may 
be randomized to either the experimental or the control 
group for intervention A and then to either experimental or 
control group for intervention B. Alternatively, they may be 
randomized simultaneously in the four groups of the 2 × 2 
factorial design (Montgomery et  al., 2003; Machin and 
Fayers, 2010).
Sample size for a 2 × 2 factorial design
When the main reason for the trial is to compare the sepa-
rate impacts of two interventions within the same trial, the 
approach to sample size calculations is relatively straight-
forward and it is common to consider the trial as two 
separate two-arm trials. The sample size for each of the 
separate comparisons is calculated and whichever of these 
results in the largest number of patients provides the basis 
for the overall sample size. These separate calculations are 
likely to be similar if the same outcome is used for both 
(Brookes et al., 2001; Montgomery et al., 2003). However, 
if the outcome and/or the assumptions are ‘different’, then 
the required sample for each intervention may be differ-
ent. When the study must be powered to specifically detect 
interaction, the factorial design loses its efficiency as the 
required sample size must be increased dramatically. For 
example, to be able to detect an interaction effect equal to 
the effect of the treatments under study, a 4-fold increase in 
the sample is required (Brookes et al., 2001; Montgomery 
et al., 2003).
Example of factorial design in orthodontic research
We are interested in evaluating the amount of torque loss/
final position of maxillary incisors during retraction in first 
maxillary premolar extraction class  II/1 cases. We would 
like to compare the effect on torque loss/maxillary incisor 
position for both wire types 0.019 × 0.025 stainless steel 
(SS) and 0.19 × 0.25 reverse curve NiTi (RC-NiTi) and 
bracket type [Self-ligating (SLB) or Conventional (CB)] at 
the same time. The details for this 2 × 2 factorial design are 
shown in the upper part of Table 1.
One way to analyse the data from this trial would be to 
perform pair-wise comparisons among all available groups 
shown in Table 1 (lower part). This analysis will compare 
A versus B, A versus C, A versus D, B versus C, B versus D, 
and C versus D. This approach, although often used, has the 
following problems.
It invokes the problem of multiplicity and the likelihood 
of false-positive findings related with multiple compari-
sons. It is expected that at an alpha level of 5 per cent, for 
every 20 tests, one test shall be positive only by chance. 
In other words, as we increase the number of statistical 
comparisons, the probability of observing a statistically 
significant finding just by chance increases. This has been 
well documented in the biomedical literature (Oxman and 
Guyatt, 1992; Assmann et al., 2000).
False-positive results may lead to over-interpretation of 
findings based solely on P values, selective reporting, and 
publication bias (Hahn et al., 2000). Investigators may be 
tempted to focus, in the presentation of their results, on 
what is statistically significant and not on what is clinically 
significant. Readers may interpret research findings on the 
basis of statistical significance or no significance, with little 
regard to clinical importance, as there is a misconception 
that a low P value means a strong clinical effect (Goodman, 
1999). Additionally, it has been reported in biomedical lit-
erature in general, and also in orthodontics, that studies with 
statistically significant findings are more likely to be pub-
lished compared with studies reporting no significant find-
ings (Moscati et  al., 1994, Rosenthal, 1979, Scholey and 
Harrison, 2005; Hopewell et al., 2007; Koletsi et al., 2009). 
Therefore, if only a subsample of the trials is published, 
then clinical decisions may be based on only a part of the 
existing evidence.
Because comparisons are performed on subgroups, these 
tests have low power as the subgroups have smaller samples 
in relation to the calculated sample. Low power may hide a 
clinically important effect if conclusions are based only on 
P values (Yusuf et al., 1991). This statement may contra-
dict the previous point; however, during subgroup analyses, 
power is lost; additionally a strong effect may appear, which 
could be a chance finding.
The above approach that resorts to subgroup compari-
sons defeats the purpose of a factorial design as the selected 
comparisons require larger sample sizes.
A more appropriate approach to data analysis would be 
to make the following comparisons under the assumption 
Table 1 Factorial design for simultaneously assessing the effect 
of wire type and bracket type on torque loss during maxillary 
anterior teeth retraction in class II/1 extraction cases.
Wire type
0.19 × 0.25 
Stainless steel
0.19 × 0.25 
Reverse curve 
NiTi
Bracket type Self-ligating A B
Conventional C D
Subgroup  
comparisons
A versus B
A versus C
A versus D
B versus C
B versus D
C versus D
Main effects  
comparisons
A+B versus C+D
A +C versus B + D
Possible comparisons among subgroups and for main effects (lower part 
of the table).
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of no interaction between wire type and bracket type; then 
we can conduct the two following comparisons of the main 
effects (Table 1, lower part).
1. A+B versus C+D. This compares the torque loss between 
the two bracket types and assumes that torque loss dif-
ference between SLB versus CB does not change as the 
type of wire changes (no interaction assumption). In 
other words, torque loss difference is the same for, let us 
say, SLB versus CB regardless of using the regular SS 
wire or the reverse curve wire.
2. A+C versus B+D. This compares the torque loss between 
the wire types and assumes that torque loss difference 
between SS versus RC-NiTi does not change as the type 
of bracket changes (no interaction assumption). In other 
words, torque loss difference is the same for, let us say, 
the SS versus RC-NiTi wire regardless of the use of SLB 
or CB.
We can determine the required sample size by calculating 
the sample size for both comparisons (A+B versus C+D 
and A+C versus B+D) and then take the larger sample size 
required (if different). So, let us say that the expected torque 
loss in the SS wire is 10 degrees and that we would like to 
be able to observe a 3-degree difference between the two 
wire types, with alpha = 0.05 and power = 90 per cent. We 
assume the standard deviations (SD1, SD2) for both groups 
are the same and equal to 5 degrees. Sample calculations are 
based on assumptions that are derived from previous publi-
cations or from piloting. The assumption of equal standard 
deviations is common, but it could be easily changed and 
applied according to the specific circumstances.
We will use the following formula (Pocock, 1983):
 
n f= (α β χ
µ µ
, )
( )
.
2
1 2
2
2
SD
-
Formula 1. This formula is used for sample calculation 
for two means, normally distributed quantitative outcomes, 
equal trial-arm allocation ratio, and two-sided tests, where 
μ1 = anticipated mean torque loss on the standard treat-
ment (CB), μ2 = anticipated mean torque loss on the 
alternative treatment (SLB), SD = standard deviation 
for torque loss (assumed the same on both arms), α = 
type I  error (significance level), β = type II error (1  − 
β  =  power), and f(α,β) is a function of α and β derived 
from the standard normal distribution and their values are 
given in Table 2. 
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−
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Therefore, the answer is 58.33 per treatment arm for a total 
of 118 patients (rounded up), and this is the sample size for 
the comparison of treatment arms A+C versus B+D.
With the same assumptions for the comparison between 
bracket types A+B versus C+D, the sample calculation will 
yield again the same number per treatment arm (59).
Therefore, in the absence of interaction, we can assess the 
effects of both bracket type and wire type at the same time 
using the sample required to assess the effect of only one 
comparison, which in this example will be 59 patients per 
arm or a total of 118 patients. Provisions for losses to fol-
low-up should also be considered. If the assumptions were 
different in terms of the expected mean values and variances 
for one of the main effects comparison, then a different sam-
ple size would have resulted from the calculation. In this 
scenario, the larger sample from the two calculations would 
have been required.
In the presence of interaction, the factorial design requires 
a sample size similar to the size required for two separate 
two-arm parallel trials (four-arm trial) and therefore there is 
no real advantage in terms of sample size (Brookes et al., 
2001; Montgomery et al., 2003; Wang and Bakhai, 2006). 
In this case, comparisons should be performed within strata 
and if no upward sample adjustments are made, the study 
would be underpowered. Therefore, when we expect an 
interaction and the primary intention of the study is not to 
detect the interaction, the 2 × 2 factorial designs becomes a 
four-arm trial and sample sizes are determined accordingly. 
In this scenario, two separate trials could be carried out, one 
comparing torque loss for SLB versus CB and one compar-
ing torque loss for SS versus RC-NiTi. A factorial design 
powered to detect interaction is a very useful tool, if not 
the only one available, to assess whether the effect of one 
parameter depends on the other parameter under investiga-
tion (Wang and Bakhai, 2006).
Finally, when designing a trial to ‘specifically’ detect a 
level of interaction (3 degrees in this example) equal to the 
difference to be detected between the two treatment arms 
(either in wire type or bracket type), the required sample 
size must be increased four times compared with the same 
design with no interaction for a total of 472 participants 
(Brookes et al., 2001; Montgomery et al., 2003).
We will proceed with sample calculation for interaction 
in more detail. We showed earlier that if we want to detect a 
difference of 3 degrees between bracket types or wire types 
(same assumptions for both interventions), SD1 = SD2 = 5 
Table 2 Values of the function f(α,β) for different values of 
alpha and beta.
β
0.05 (95% 
power)
0.1 (90% 
power)
0.2 (80% 
power)
0.5 (50% 
power)
α 0.05 13.0 10.5  7.85 3.84
0.01 17.8 14.9 11.7 6.63
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degrees, power  =  0.90, and alpha  =  0.05; in the two-arm 
parallel-trial scenario, we would need a total 118 participants 
for both arms.
Suppose now that we want to conduct a factorial design 
trial for wire type and bracket type on torque loss with the 
objective to specifically assess interaction.
The main effects and the interaction comparisons will be 
the following.
1. Main effect for wire: the treatment effect of SS versus 
RC-NiTi wire regardless of bracket type.
2. Main effect for bracket: the treatment effect of SLB ver-
sus CB regardless of wire type.
3. Interaction: Torque loss (SLB/SS − SLB/RC-NiTi) − Torque 
loss (CB/SS − CB/RC-NiTi) or Torque loss (SS/SLB − SS/
CB) − Torque loss (RC-NiTi/SLB − RC-NiTi/CB)
The next step, as in the usual sample size calculations, 
would be to decide what would be the minimum differ-
ence of clinical importance that we would like to detect. 
Previously, we used as a minimum difference 3 degrees for 
the main effects comparison (scenarios 1 and 2 above) and 
we will use the same difference for the interaction com-
parison ( scenario 3 above; Altman & Bland, 2003). We 
assume the standard deviation is equal in all four subgroups 
(SD1 = SD2 = SD3 = SD4) and that it is 5 degrees. When 
the objective of the study is to specifically detect interac-
tion, the required sample size must be increased dramati-
cally (4-fold in this example; Brookes et al., 2001).
When we compare two groups, the standard deviation 
used for the test is not SD1 minus SD2 but SD1+ SD2, 
because the standard deviation of the difference of the com-
parison groups is expected to be higher than the individual 
group standard deviations. This is counterintuitive because 
we would think the standard deviation of the difference is 
equal to the difference of the standard deviations, and it is 
important to realize that it is the sum of the standard devia-
tions. From Formula 1, we know that as the standard devia-
tion increases, so does the required sample size. For the 
interaction test, we have four subgroups and to assess their 
combined difference, we calculate the standard deviations as 
the sum of all subgroup standard deviations [= 4 SD], which 
would give a variance equal to 4 × 52=100, which is the vari-
ance for the interaction test including four subgroups (each 
subgroup variance = SD2 = 25).
Statistical analysis
The statistical analysis selected will depend on the type of 
outcome and the research question. A classic approach for 
the 2 × 2 factorial designs when the outcome is continuous 
as in our example (torque loss in degrees) is the two-way 
analysis of variance (two-way ANOVA), similar to a mul-
tivariable linear model with two predictors. The regression 
model may be written as follows:
 y = β β χ β χ0 + +× ×bracket bracket wire bracket  (1)
Here, y is the outcome measurement of torque loss in 
degrees, β0=  the expected torque loss in degrees for the 
reference bracket (CB) and wire (SS) groups, χbracket = 1 
and 0 for bracket SLB and bracket CB, respectively, and 
χwire  = 1 if RC-NiTi wire is given and 0 for SS wire. In 
this equation, we selected CB and SS as the baseline or ref-
erence groups, but we could have easily selected SLB and 
RC-NiTi as the reference and modified the interpretation 
accordingly.
To test for interaction between bracket and wire, Equation 1 
may be expanded as follows: 
y = + + × + ××β β χ β χ β χ0 bracket bracket wire bracket bracket brackwire etwire  (2)
Here, y is the outcome measurement (torque loss) in 
degrees; β0 , χbracket , χwire  are the same as for Equation 1, 
and βbracket bracketwire wire× χ  is the interaction term. The interac-
tion term may be considered as the value that the estimates 
should be adjusted for in order to get the correct values 
when we assume that the effect of bracket type is influenced 
by the effect of wire type.
In the current example, the main analysis computes only 
main effects, i.e. the effects of bracket type and wire type on 
torque loss independently as there is no interaction assump-
tion. Depending on the type of the intervention, it is natural 
to be interested to know whether the effect of treatment may 
be different between subgroups. As explained earlier, sub-
group analyses have certain problems associated with them. 
A better approach to test for possible differences would be 
to perform an interaction test as shown in Equation 2 (Yusuf 
et  al., 1991; Assmann et  al., 2000) However, interaction 
tests have low power and if the objective is to test for the 
presence of interaction or to compare certain subgroups, the 
study should be powered accordingly as it is incorrect to 
select a sample based on a certain comparison and then use 
the same sample to make comparisons not intended during 
the pre-trial sample calculations.
Informal assessment of interaction
We can conduct a statistical test to assess the presence 
of interaction; however, as already mentioned, these tests 
suffer from low power. We can also conduct an informal 
interaction test by looking at the tabulated results under two 
scenarios of torque loss differences (Table  3). Again, we 
have interaction when the effect of bracket type on torque 
loss measured in degrees is different at the two different 
levels of the variable ‘wire type’. Therefore, we would like 
to see whether torque loss difference between SLB versus 
CB is the same for patients with SS wire and those with 
RC-NiTi wire and we can study this as follows.
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If there is no interaction, the difference in torque loss 
between CB and SLB should be similar in both SS and 
RC-NiTi wire patients, and if there is interaction, the differ-
ence in torque loss between the bracket CB and SLB should 
be different between SS and RC-NiTi wires. In Table 3, the 
differences in torque loss (between CB and SLB, subpart 
a) are similar (1 versus 2 degrees) regardless of the type 
of wire; in this case, no interaction is suspected. On the 
contrary, in section ‘b’ of Table 3, the differences in torque 
loss (between CB and SLB) are large (3 versus 10 degrees), 
indicating presence of interaction (Matthews and Altman, 
1996a,b).
The same question could be asked the other way around. 
Is the difference in torque loss between SS and RC-NiTi 
groups modified depending on the type of bracket? 
Comparing the differences by row or by column is a quick 
method for checking for interaction without statistical test-
ing. However, it should be kept in mind that the presence or 
absence of interaction may depend on the scale of measure-
ment. For example, absence of interaction on an additive 
scale may not preclude absence of interaction on a multipli-
cative scale (Brittain and Wittes, 1989).
To further elaborate on the issue of subgroup comparisons 
versus interaction testing, it is likely that if we adopt sub-
group comparisons like SLB versus CB separately within 
the SS and RC-NiTi groups and the sample size is differ-
ent between subgroups, it is possible to obtain conflicting 
results. For example, as the P value depends on sample size 
and variance, even though the clinical difference is small 
and indicates no interaction, the P value may be significant 
in one of the subgroup comparisons (Table 4). This type of 
problem is avoided with the use of an interaction test and 
conclusions are not drawn based on P values from under-
powered subgroup analyses (Altman and Bland, 2003).
Reporting
Reporting of factorial designs should follow the guidelines 
proposed by the Consolidated Standards of Reporting Trials 
(CONSORT) statement as closely as possible (Moher et al., 
2010); however, specific guidelines for factorial designs 
are not yet available. A key issue is that in case interaction 
is detected, then estimates should be reported per stratum 
or estimates should be calculated after considering the 
calculated value of the interaction term (Lubsen and 
Pocock, 1994). In other words, if together with the main 
effects the interaction term is calculated after applying a 
regression model, the correct estimates that incorporate 
the interaction effect can be easily calculated. If there is 
interaction that cannot be detected due to low power when 
sample size for the factorial design is selected under the no 
interaction assumption, then the problem of interpretation 
will depend on whether the interaction is qualitative or 
quantitative. For quantitative interaction, usually the issue 
would be that the main effects will overestimate the effects 
for some individuals and underestimate them for some 
others. Although the interaction and the means of the four 
cells must be presented, the main effects may still be a 
reasonable representation of the intervention effects either 
separately or combined. On the other hand, if the interaction 
is qualitative, such change of direction of effect between 
subgroups and presenting the combined results would be 
most likely misleading (Montgomery et al., 2003).
Conclusion
•	 A factorial design of an RCT allows assessment of two 
treatments at the same time on the same sample.
•	 If the conditions are satisfied (no interaction between 
the two treatments, interventions may be combined), the 
factorial design allows using half of the sample required 
for the corresponding two separate two-arm parallel 
trials.
Table 3 Tabulation for informal assessment of interaction.
a. 0.019 × 0.025 
Stainless steel
0.019 × 0.0 25 
NiTi
Difference
 Self-ligating 5 4 1
 Conventional 7 5 2
Difference 2 1 —
b. 19 × 25 SS 19 × 25 NiTi Difference
 Self-ligating 5 2 3
 Conventional 13 3 10
Difference 8 1 —
a. shows that the difference in effect between self-ligating and 
conventional brackets is similar in the presence of either the 0.19 × 0.25 
SS wire (2 degrees) or the presence of the 0.019 × 0.025 NiTi wire (1 
degrees). Similarly, the difference between wire types is similar in 
the presence (1 degree) or absence of the self-ligating appliance (2 
degrees) 
b. shows that the difference in effect between self-ligating and 
conventional brackets is different in the presence of either the 
0.19 × 0.25 SS wire (8 degrees) or the presence of the 0.019 × 0.025 NiTi 
wire (1 degrees). Similarly, the difference between wire types is similar 
in the presence (3 degree) or absence of the self-ligating appliance (10 
degrees)
Table 4 Subgroup comparisons may yield conflicting results 
if the focus is on statistical significance as P values depend on 
sample size and variance. 
0.019 × 0.025 
Stainless steel
0.019 × 0.0 25 
RC-NiTi
Difference P value
Self-ligating 5 4 1 <0.05
Conventional 7 5 2 >0.05
— 2 1 — —
In the first test, we are assuming large sample size, and in the second, a 
small sample size, whereas standard deviation is assumed the same for 
all group means. 
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•	 The factorial design is the only approach that allows the 
assessment of two or more interventions simultaneously 
and the evaluation of interactions. If the objective of the 
factorial design is to detect interaction(s), the sample size 
must be dramatically increased.
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